Purpose: For the 1.5 T Elekta MR-Linac it is essential that the optimisation of a treatment plan accounts for the electron return effect on the planned dose distribution. The ability of two algorithms for the first stage fluence optimisation, pencil beam (PB) and Monte Carlo (MC), to produce acceptable plan quality was investigated. Optimisation time for each algorithm was also compared.
example at the patient's skin or internal air cavities. Which can result in increases of up to 56% for a single beam at highly oblique surfaces. 4 The B-field also influences the path of the electrons in tissue with differences seen in the percentage depth dose curves and field profiles. 3 However, despite these effects, when the planning system accounts for the ERE clinically acceptable plans can be created. This is possible as the Monte Carlo (MC) algorithm accurately models the dose caused by the ERE, which can then be accounted for and removed by the modulation of the fields when IMRT is utilized. [4] [5] [6] Planning studies have been conducted for rectum 7 and lung SBRT 5 leading to clinically acceptable plans, this has also been shown for pancreatic, head and neck, breast, and lung cases, 6 where optimising including the B-field was shown to remove the effects of the ERE.
Plan creation for the MR-Linac will utilize the Monaco treatment planning system (Elekta AB, Stockholm, Sweden), which uses a two-stage method to optimize the dose. 8 The first stage is fluence optimisation and the second is segment shape optimisation. The dose calculation in the second stage is always MC which includes the effect of the 1.5 T B-field in the dose calculation using the GPUMCD algorithm 9 and has been shown to produce acceptable results when compared against GEANT4. 10 However, for the first stage of the optimisation the user has the option to use either a Pencil Beam (PB) or the MC algorithm. The PB algorithm does not account for the B-field, but has the benefit of being very fast, whereas the MC algorithm will account for the B-field but is much slower.
It is unknown whether using MC in the first stage (i.e., accounting for the B-field) improves the final plan quality or if we can use the PB algorithm in stage 1 and recover the plan, accounting for the B-field, in stage 2 only. The latter option could save a significant amount of time in plan creation. Therefore, it is the purpose of this paper to compare plan quality for plans optimized in stage 1 with PB with those optimized with the MC algorithm. Additionally, a comparison of the MUs required for each plan as a surrogate for plan complexity 11, 12 and the total time taken to optimize using each method will be compared.
| MATERIALS AND METHODS

2.A | Patient selection
Ten head and neck, ten lung and five prostate patients, all treated curatively at the authors institution, were randomly selected from the clinical archive. All target volumes and organs at risk (OAR) had been delineated at the time of planning by a radiation oncologist specialising in the relevant treatment site. were kept constant between plans; details of these are shown in Table 2 . This ensures that the plan comparison is between the stage 1 dose calculation and is not influenced by the objective functions or optimisation parameters.
2.B | Choice of segmentation parameters
2.D | Analysis of results
The relevant dose statistics to the PTVs and the OARs important for each site were recorded, as documented in Table 3 The time taken to optimize each plan was measured, from initiating stage 1 optimisation to the end of the dose calculation, to assess the usability of each method. Additionally, the total number of MUs was also recorded to provide an estimate of deliverability. 11 
| RESULTS
Different segmentation parameters were tested for a representative lung plan. Table 4 shows that the number of MUs was much greater for plans that allowed more segments but the MUs were not significantly (P < 0.01) different between PB and MC for any choice of segmentation parameters. Additionally, regardless of choice of segmentation parameters the time taken using the MC algorithm was always much larger but decreases from being 20 times larger to 6 times larger going from complex to more simple segments. The variation in the DVH parameters for the target and
OARs can be seen in Table 5 . The differences between using the PB and MC algorithms for the three different segmentation parameters are all below 2% and mostly below 1%, highlighting that segmentation parameters have a small effect on the outcome of this comparison.
The average MUs and optimisation time over the number of patients planned for each treatment group are shown in Table 6 .
This shows the average time taken to optimize using the PB and MC algorithms, as well as the average number of MUs. The standard deviation is shown in parentheses. The DVH parameters evaluated (Table 3) for lung patients with the PB and MC algorithm are shown in Fig. 1 . Figures 2 and 3 show the same data for ten head and neck patients, and five prostate patients respectively.
Most parameters showed with little difference between the two optimisation arms. The DVH parameters that showed statistically significant difference (at P < 0.01 which was chosen due to the low number of patients) are denoted in the plots with a *. The H&N patients show a significant difference for the maximum dose to 2 cc of the skin, with the PB plans being 1.3% higher which is not considered clinically significant. The prostate plans showed no significant differences between the optimisation arms.
Some parameters were statistically significant for the lung cases but these were not considered clinically significant on discussion with a consultant oncologist. Specifically, a difference for the Heart V10 was seen of 2.4%, with the MC arm showing a higher dose. that there were no clinically significant changes in the DVH parameters between using the two algorithms for the first stage of the optimisation. Nonetheless there is a large increase (~10 times) in the time taken to optimize when using the MC algorithm. Only five parameters showed a statistically significant dosimetric difference between plans produced using the MC or PB algorithms. These differences between the arms were all less than 2.5% and on discussion with a consultant oncologist were not considered clinically important.
This work has investigated two optimisation arms, PB or MC, for head and neck plans, lung plans and prostate plans to cover a range of anatomical sites with varying amounts of inhomogeneities present.
Interestingly, even the lung plans showed minimal differences between the optimisation arms. Because of the large inhomogeneities and
The mean and standard deviation in the number of MUs and time taken to optimise the plans is shown. The two different algorithms used for the fluence optimisation stage, PB and MC are shown for three different anatomical sites. The P-values for a paired t-test are also shown in bold. T A B L E 5 DVH parameters for the PTV IMRTs, both lungs, heart, skin and lung surface for the three different segmentation parameter choices used (see Table 1 ) for a representative lung plan. Differences above 1% are highlighted in red/italics. The intermediate segment parameters were utilized for the rest of the patients, these are highlighted in bold. tissue/air interfaces it was expected that using the MC algorithm for fluence optimisation would work better as it accounts for the B-field and associated ERE during optimisation. There were statistically significant differences for four of the DVH parameters for the lung plans but none of these were considered clinically significant. Apparently the changes in dose distribution due to ERE are so localized that the segment weight optimization in the second stage, where MC accounting for the B-field was used, could fully recover the plan quality.
Mean (SD)
Several papers have shown that Monaco is capable of producing clinically acceptable plans for linacs with a 1.5 T B-field. [5] [6] [7] However, to our knowledge none have investigated the effect of the fluence optimisation method on plan quality. This is the first paper to investigate whether the choice of algorithm in the first stage of optimisation makes a difference on plan quality for the MR-Linac. The results obtained here could also be true at 0 T, applicable for standard linacs but this has not been investigated here.
One of the limitations of this study was that the segmentation parameters were kept constant for each plan site. We initially tested several sets of parameters for a lung plan. Changing from 60 to 180 segments per plan, as well as from 3 cm 3 to 12 cm 3 for the minimum segment area kept differences between PB and MC algorithms below 1% for most DVH parameters, with only 5 parameters between 1% and 2%. Therefore, we believe that the choice of segmentation parameters does not change the overall conclusion. We have investigated head and neck, thorax and pelvis regions to have a range of anatomy, and since in all three the first stage optimization made no difference we expect this conclusion to hold for further treatment sites.
The number of MUs has been used as a surrogate measure for complexity and whilst other metrics have been proposed, 12 the number of MUs is still thought to give an indication of the complexity of a plan 11, 12 and is easily extracted from the plans. The optimisation method showed no significant difference in the plan MU, indicating no measurable difference in complexity between plans.
This work illustrates that using the faster PB algorithm for fluence optimisation does not degrade the plan quality or reduce plan deliverability. 
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